CJC-1295: DAC vs No-DAC Forms, Half-Life & Literature Context (2026)

"CJC-1295" in online peptide discussions usually means the GHRH analogue without DAC (drug affinity complex), sometimes contrasted with a longer-acting DAC-modified form in research literature. Half-life and dosing interval assumptions depend on which analogue you actually have.

Interval and depot effects

Longer-acting variants change accumulation if people dose on a short-interval schedule designed for the shorter form. Read the supplier identity statement and any third-party identity testing before planning dilutions.

Combination stacks in papers

Animal studies sometimes pair GHRH analogues with ghrelin mimetics such as ipamorelin; interaction effects mean a dose studied in isolation is not automatically valid in combination.